Results 71 to 80 of about 6,859 (188)

Endocrinologist‐Led Management of Endocrine Immune‐Related Adverse Events: Real‐World Evidence Supporting the Japan Endocrine Society Guidelines

open access: yesCancer Medicine, Volume 15, Issue 4, April 2026.
During the study period, 709 patients were treated with immune checkpoint inhibitors (ICIs) at our institution. Endocrine immune‐related adverse events (irAEs) were diagnosed in 84 patients, all of whom were evaluated and managed by endocrinologists; the most common irAEs were thyroid dysfunction (64.3%) and adrenal insufficiency (42.9%), followed by ...
Kota Nishihama   +10 more
wiley   +1 more source

Postural Orthostatic Tachycardia Syndrome Presenting With Recurrent Syncope After Cervical Spinal Cord Injury

open access: yesClinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Syncope is a manifestation of autonomic dysfunction after high spinal cord injury. However, it is rarely reported as a feature of postural orthostatic tachycardia syndrome (POTS) after spinal cord injury. This case report describes a male in his 50s suffering from C2 spinal cord injury who developed recurrent postural syncope post‐injury ...
Yonghong Liu, Boyan Fang, Qiaoxia Zhen
wiley   +1 more source

Effects of mineralocorticoid receptor stimulation via fludrocortisone on memory in women with borderline personality disorder

open access: yes, 2015
In a previous study, we found that in contrast to healthy controls, hydrocortisone administration had enhancing effects on memory in patients with borderline personality disorder (BPD).
Otte, C.   +6 more
core   +1 more source

Renal tubular acidosis: A ‘basic’ disorder

open access: yes
Equine Veterinary Education, Volume 38, Issue 7, Page 365-366, July 2026.
H. J. Mason, L. G. Arroyo
wiley   +1 more source

Severe Headache and Acute Blindness: A Case of Pituitary Apoplexy

open access: yesClinical Case Reports, Volume 14, Issue 3, March 2026.
ABSTRACT Pituitary apoplexy is a rare, life‐threatening syndrome that commonly occurs in the adenomatous pituitary gland. It presents with a myriad of severe neuroendocrine and ophthalmological signs and symptoms. Early diagnosis and prompt treatment are vital in the management of pituitary apoplexy.
Abdul‐Rahman Faiza   +4 more
wiley   +1 more source

Population pharmacokinetic - pharmacodynamic modeling of fludrocortisone

open access: yes, 2017
Introduction. Les corticoïdes sont supposés avoir des effets bénéfiques à faibles doses chez les patients en choc septique réfractaire. Ces effets ont été retrouvés dans plusieurs études utilisant l’hydrocortisone.
Hamitouche, Noureddine
core  

Fludrocortisone for orthostatic hypotension

open access: yesCochrane Database of Systematic Reviews, 2017
Orthostatic hypotension is an excessive fall in blood pressure (BP) while standing and is the result of a decrease in cardiac output or defective or inadequate vasoconstrictor mechanisms. Fludrocortisone is a mineralocorticoid that increases blood volume and blood pressure. Fludrocortisone is considered the first- or second-line pharmacological therapy
Stephanie, Veazie   +6 more
openaire   +3 more sources

The role of fludrocortisone in cognition and mood in patients with primary adrenal insufficiency (Addison's disease)

open access: yes, 2016
BACKGROUND: Primary adrenal insufficiency (AI) requires hormone replacement therapy with fludrocortisone and hydrocortisone stimulating glucocorticoid (GR) and mineralocorticoid receptors (MR).
Schultebraucks, K.   +3 more
core   +1 more source

Spontaneous intracranial hypotension syndrome treated with fludrocortisone [PDF]

open access: yes, 2015
Spontaneous intracranial hypotension is a rare syndrome characterized by orthostatic headache not associated with trauma or dural puncture.
Ayoub, Sophie D.   +6 more
core   +1 more source

Posterior Reversible Encephalopathy Syndrome in a Patient with Multiple System Atrophy and Multiple Myeloma

open access: yes
Movement Disorders Clinical Practice, Volume 13, Issue 5, Page 1326-1330, May 2026.
Jackson Mitzner   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy